Bobang Fangzhou Medical Technology

Bobang Fangzhou Medical Technology

Private
Beijing, BeijingHealthcare & Life Scienceshttp://www.ghalife.com

Last Round

Series A

May 7, 2021

Total Funding Raised

$7.72M

Company Overview

Bobang Fangzhou Medical Technology is a Chinese company founded in 2017 that develops non-invasive glucose meters. The company's devices utilize a metabolic heat integration method and multi-sensor technology for rapid blood glucose measurement without finger pricking. One of its products is the GHA NIGA01, which has been evaluated in clinical studies. The company is associated with Global Health Ark Medical Technology (Beijing) Co. Ltd. and uses the brand name GHA. Bobang Fangzhou Medical Technology raised $7.72 million in a Series A funding round in May 2021, with investors including Fortune Capital, Tasly, and China Venture Capital.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Consumer Electronics, Sensors

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

non-invasive blood glucose meterno-prick glucose monitorneedle-free glucose monitorblood glucose monitoringdiabetes techdiabetes managementconsumer medical deviceat-home monitoringmedical hardwarehealth IoTcompanion mobile appmetabolic heat integrationmulti-sensor technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bobang Fangzhou Medical Technology Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Bobang Fangzhou Medical Technology Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMay 7, 2021
VC RoundOct 31, 2019

Bobang Fangzhou Medical Technology Investors

Notable investors and investment history

Bobang Fangzhou Medical Technology Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bobang Fangzhou Medical Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bobang Fangzhou Medical Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing, Beijing
Year Founded2017
Last FundingMay 7, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.